IDXX
IDEXX Laboratories Inc
NASDAQ: IDXX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$553.66
-2.58% today
Updated 2026-04-29
Market cap
$44.08B
P/E ratio
42.36
P/S ratio
10.24x
EPS (TTM)
$13.07
Dividend yield
—
52W range
$465 – $770
Volume
0.5M
WallStSmart proprietary scores
61
out of 100
Grade: C+
Hold
Investment rating
6.7
Growth
B5.0
Quality
C+9.5
Profitability
A+2.7
Valuation
F5/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$724.50
+30.86%
12-Month target
$392.50
-29.11%
Intrinsic (DCF)
$440.68
Margin of safety
-47.21%
4 Strong Buy5 Buy5 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 24.60% — above average
+ ROE 66.20% — strong efficiency
+ Free cash flow $322.59M — positive
+ Revenue growth 14.30% QoQ
Risks
- 47.21% above intrinsic value
- P/E 42.36x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $3.37B | $3.66B | $3.90B | $4.30B | $4.30B | $4.7B |
| Net income | $679.09M | $845.04M | $887.87M | $1.06B | $248.19M | — |
| EPS | — | — | — | — | $13.07 | $14.82 |
| Free cash flow | $394.15M | $772.88M | $798.08M | $1.05B | $322.59M | — |
| Profit margin | 20.17% | 23.08% | 22.78% | 24.62% | 24.60% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-03 | UNDERBERG, SHARON E. | Sale | 197 | — |
| 2026-03-03 | UNDERBERG, SHARON E. | Buy | 197 | $505.53 |
| 2026-03-03 | HUNT, NIMRATA | Sale | 1,758 | $634.57 |
Peer comparison
Smart narrative
IDEXX Laboratories Inc trades at $553.66. representing a P/E of 42.36x trailing earnings. Our Smart Value Score of 61/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. TTM revenue stands at $4.30B. with profit margins at 24.60%. Our DCF model estimates intrinsic value at $440.68.
Frequently asked questions
What is IDEXX Laboratories Inc's stock price?
IDEXX Laboratories Inc (IDXX) trades at $553.66.
Is IDEXX Laboratories Inc overvalued?
Smart Value Score 61/100 (Grade C+, Hold). DCF value $440.68.
What is the price target of IDEXX Laboratories Inc (IDXX)?
The analyst target price is $724.50, representing +30.9% upside from the current price of $553.66.
What is the intrinsic value of IDEXX Laboratories Inc (IDXX)?
Based on our DCF model, intrinsic value is $440.68, a -47.2% margin of safety versus $553.66.
What is the future stock price of IDXX by 2030?
Our research-backed model estimates IDEXX Laboratories Inc could reach $968.23 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is IDEXX Laboratories Inc's revenue?
TTM revenue is $4.30B.
Piotroski F-Score?
5/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio10.24x
ROE66.20%
Beta1.72
50D MA$592.25
200D MA$640.81
Shares out0.08B
Float0.08B
Short ratio—
Avg volume0.5M
Performance
1 week-1.30%
1 month-1.46%
3 months-18.18%
YTD-18.16%
1 year—
3 years—
5 years—